Marketdash

CVS Health Raises Revenue Targets and Unveils AI-Powered Engagement Platform

MarketDash Editorial Team
15 hours ago
CVS Health boosted its 2025 and 2026 forecasts at its investor day Tuesday, showcasing over $1 billion in cost savings reinvested into AI tools that are streamlining operations across Aetna, Oak Street Health, and Caremark.

CVS Health Inc. (CVS) laid out ambitious growth plans and showed off some impressive AI wins at its investor day Tuesday, giving Wall Street plenty to chew on.

Bumping Up 2025 Targets

The healthcare giant raised its 2025 revenue outlook to at least $400 billion, up from its previous guidance of at least $397.3 billion and comfortably ahead of analyst expectations at $394.59 billion. Operating income is projected to land between $4.37 billion and $4.54 billion.

More importantly for investors, CVS lifted its adjusted earnings per share guidance for fiscal 2025 from $6.55-$6.65 to $6.60-$6.70. That's notably higher than the Street's $6.38 consensus estimate.

Looking Ahead to 2026

For fiscal 2026, CVS Health expects revenue of at least $400 billion with operating income between $13.26 billion and $13.60 billion. The adjusted earnings forecast came in at $7.00-$7.20 per share, roughly in line with analyst expectations of $7.18.

The company is targeting mid-teens adjusted EPS compound annual growth through 2028, banking on continued strong execution across its business segments.

The AI Investment Paying Off

Beyond the numbers, Tuesday's presentation spotlighted CVS's technology push. The company introduced a new suite of products built around "Engagement as a Service," essentially an open platform designed to integrate consumer engagement across its various businesses and select partners.

The pitch is straightforward: better engagement means better health outcomes, lower costs, fewer hospital readmissions, and more personalized services. And the company claims it's already seeing results.

According to CVS, the company has saved more than $1 billion that it's plowing back into growth initiatives and artificial intelligence development. Here's where those savings are showing up:

  • At Aetna, consolidating clinical documentation is saving nurses 90 minutes per day. Call center volume has dropped 30%, and the company has consolidated four separate care management systems into one.
  • Oak Street Health, which operates primary care centers, now has ambient AI scribe tools deployed at 90% of its facilities, reducing administrative burden on physicians.
  • CVS Caremark's pharmacy benefit management system can now handle more than 300 claims per second during peak periods while maintaining a 99% first-call resolution rate.

Those aren't just incremental improvements. Saving nurses an hour and a half daily or cutting call volume by nearly a third translates to real operational leverage at scale.

CVS Price Action: CVS Health shares climbed 3.18% to $78.96 at the time of publication Tuesday.

CVS Health Raises Revenue Targets and Unveils AI-Powered Engagement Platform

MarketDash Editorial Team
15 hours ago
CVS Health boosted its 2025 and 2026 forecasts at its investor day Tuesday, showcasing over $1 billion in cost savings reinvested into AI tools that are streamlining operations across Aetna, Oak Street Health, and Caremark.

CVS Health Inc. (CVS) laid out ambitious growth plans and showed off some impressive AI wins at its investor day Tuesday, giving Wall Street plenty to chew on.

Bumping Up 2025 Targets

The healthcare giant raised its 2025 revenue outlook to at least $400 billion, up from its previous guidance of at least $397.3 billion and comfortably ahead of analyst expectations at $394.59 billion. Operating income is projected to land between $4.37 billion and $4.54 billion.

More importantly for investors, CVS lifted its adjusted earnings per share guidance for fiscal 2025 from $6.55-$6.65 to $6.60-$6.70. That's notably higher than the Street's $6.38 consensus estimate.

Looking Ahead to 2026

For fiscal 2026, CVS Health expects revenue of at least $400 billion with operating income between $13.26 billion and $13.60 billion. The adjusted earnings forecast came in at $7.00-$7.20 per share, roughly in line with analyst expectations of $7.18.

The company is targeting mid-teens adjusted EPS compound annual growth through 2028, banking on continued strong execution across its business segments.

The AI Investment Paying Off

Beyond the numbers, Tuesday's presentation spotlighted CVS's technology push. The company introduced a new suite of products built around "Engagement as a Service," essentially an open platform designed to integrate consumer engagement across its various businesses and select partners.

The pitch is straightforward: better engagement means better health outcomes, lower costs, fewer hospital readmissions, and more personalized services. And the company claims it's already seeing results.

According to CVS, the company has saved more than $1 billion that it's plowing back into growth initiatives and artificial intelligence development. Here's where those savings are showing up:

  • At Aetna, consolidating clinical documentation is saving nurses 90 minutes per day. Call center volume has dropped 30%, and the company has consolidated four separate care management systems into one.
  • Oak Street Health, which operates primary care centers, now has ambient AI scribe tools deployed at 90% of its facilities, reducing administrative burden on physicians.
  • CVS Caremark's pharmacy benefit management system can now handle more than 300 claims per second during peak periods while maintaining a 99% first-call resolution rate.

Those aren't just incremental improvements. Saving nurses an hour and a half daily or cutting call volume by nearly a third translates to real operational leverage at scale.

CVS Price Action: CVS Health shares climbed 3.18% to $78.96 at the time of publication Tuesday.

    CVS Health Raises Revenue Targets and Unveils AI-Powered Engagement Platform - MarketDash News